Clinical Differences That Matter for UK Patients
Mounjaro or Wegovy Which Is Better: Mechanism Comparison
Understanding whether Mounjaro or Wegovy which is better starts with their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, reducing appetite and promoting satiety after smaller meals. Mounjaro contains tirzepatide, which activates both GLP-1 and GIP receptors, creating dual hormone action that may influence both appetite control and glucose metabolism. Both treatments work by targeting brain appetite centres, but through different pathways that suit different patient profiles.
The choice between these mechanisms depends on individual response patterns and health considerations. Some patients respond better to single-target GLP-1 action, while others may benefit from dual receptor activation. Both require prescription-only access through clinical assessment, as they're potent medications that must be prescribed alongside a reduced-calorie diet and increased physical activity. EverydayMeds provides both options through our GPhC-registered pharmacy, allowing your prescriber to recommend the most suitable treatment based on your medical history and weight management goals.
UK Pricing and Value When Comparing Mounjaro or Wegovy Which Is Better
Cost considerations often influence decisions about Mounjaro or Wegovy which is better for long-term treatment. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose (new customers using code FIRST40), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenient dose progression, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, designed for your first 8 weeks of treatment.
Mounjaro pricing follows a different structure due to its distinct formulation and manufacturing. When evaluating Mounjaro or Wegovy which is better from a financial perspective, consider not just initial costs but long-term maintenance pricing and practical factors like storage requirements. Wegovy's superior room temperature stability (6 weeks vs 21 days) can reduce wastage if you travel frequently or experience delivery delays. Both treatments represent significant investments in your health, and EverydayMeds offers flexible ordering options to support consistent treatment adherence.
Clinical Evidence: Mounjaro or Wegovy Which Is Better Based on Trials
The question of Mounjaro or Wegovy which is better requires examining their respective clinical trial data, though direct comparisons aren't possible due to different study designs and populations. Wegovy's evidence comes from the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks in STEP 1, compared to 2.4% with placebo. The STEP trials also demonstrated sustained weight management over 2 years and cardiovascular benefits in the SELECT trial.
Mounjaro's clinical profile stems from different trial programmes with varying endpoints and patient populations. Both treatments have undergone rigorous MHRA evaluation and received UK marketing authorisation for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. Individual response varies significantly, making clinical assessment essential for determining which treatment may be more suitable for your specific health profile and circumstances.
How Wegovy Works in Your Body
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally released in your intestines after eating. This mechanism directly targets appetite centres in your brain, particularly the hypothalamus, reducing hunger signals and promoting feelings of fullness after smaller meals. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety. Additionally, Wegovy may help reduce food cravings and the psychological drive to eat, supporting behavioural changes essential for sustainable weight management. The once-weekly injection provides consistent medication levels, maintaining appetite suppression throughout the week when combined with lifestyle modifications.
Ordering Process for UK Patients Comparing Mounjaro or Wegovy Which Is Better
Whether you choose Mounjaro or Wegovy which is better for your situation, EverydayMeds streamlines the ordering process through our regulated clinical pathway. Begin with our 3-minute online assessment covering your medical history, current medications, weight management goals, and any previous experience with GLP-1 treatments. Our qualified prescribers review all applications within 3 working days (or 24 hours with express service), evaluating which treatment option aligns with your individual needs. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics, ensuring medication integrity from our GPhC-registered pharmacy (#9012878) to your door. The entire process maintains clinical oversight while providing convenient access to these specialist weight management treatments.
Storage and Practical Considerations
Practical storage requirements often influence decisions about Mounjaro or Wegovy which is better for your lifestyle. Wegovy requires refrigeration at 2-8°C before first use but offers exceptional flexibility once removed from the fridge, remaining stable for up to 6 weeks at room temperature below 30°C. This storage advantage makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules, as you don't need immediate refrigeration access. Mounjaro requires similar refrigeration but only tolerates 21 days at room temperature, making it less forgiving for travel or storage disruptions. Both medications use pre-filled injection pens with fine needles, but Wegovy's FlexTouch system is manufactured by Novo Nordisk with decades of injection device refinement. The dose escalation schedule differs between treatments, affecting how you progress through increasing strengths over your initial months of treatment.
UK-Specific Regulatory Status for Mounjaro or Wegovy Which Is Better
Understanding the regulatory landscape helps inform decisions about Mounjaro or Wegovy which is better within the UK healthcare system. Wegovy received MHRA approval for weight management in 2021 and NICE recommendation (TA875) for use within specialist weight management services. The treatment carries additional monitoring status (Black Triangle ▼), reflecting its relatively recent introduction to the market, though extensive clinical data supports its safety profile when properly prescribed and monitored. MHRA recently approved a higher 7.2mg dose formulation in January 2026, though this isn't yet available through EverydayMeds pending supply chain establishment.
Both treatments fall under prescription-only medicine regulations, requiring clinical oversight and cannot be purchased without proper medical assessment. EverydayMeds operates under full GPhC registration, ensuring compliance with UK pharmacy regulations and providing the clinical governance necessary for these specialist medications. This regulatory framework protects patients while ensuring access to genuine, properly stored medications from licensed sources rather than unregulated online pharmacies operating outside UK jurisdiction.
Making Your Decision: Mounjaro or Wegovy Which Is Better
The ultimate decision about Mounjaro or Wegovy which is better depends on multiple individual factors that only qualified prescribers can properly evaluate. Your medical history, including any diabetes or cardiovascular conditions, may favour one mechanism over another based on additional health benefits demonstrated in clinical trials. Lifestyle factors such as travel frequency might make Wegovy's superior room temperature stability more valuable, while others may respond better to Mounjaro's dual hormone approach. Cost considerations, injection frequency preferences, and previous experience with similar medications all contribute to the decision-making process. EverydayMeds prescribers consider all these factors during clinical assessment, providing personalised recommendations rather than one-size-fits-all approaches. Both treatments are available through our service, ensuring you can access whichever option best suits your individual circumstances. Remember that successful weight management requires commitment to lifestyle changes alongside medication, regardless of which treatment you choose. Use code FIRST40 for new patients or DOSE25 for returning customers when ordering through https://everydaymeds.co.uk/collections/wegovy to access our best available pricing.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
